Interactions between inhibitors of the axonal amine pump and bretylium in the degeneration release of sympathetic transmitter.
D000588:Amines / Q000037:antagonists & inhibitors / Q000378:metabolism; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D001369:Axons / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D001949:Bretylium Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D003986:Dibenzocycloheptenes / Q000494:pharmacology; D004357:Drug Synergism; D007279:Injections, Subcutaneous; D008297:Male; D011083:Polycyclic Compounds / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013564:Sympathetic Nervous System / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D000588:Amines; D000928:Antidepressive Agents; D001949:Bretylium Compounds; D003984:Dibenzazepines; D003986:Dibenzocycloheptenes; D011083:Polycyclic Compounds; D011437:Propylamines; D003042:Cocaine; D003891:Desipramine